Publications 2021

Bjorkto MH, Barratt-Due A, Nordoy I, Dorje C, Galteland E, Lind A, Hilli A, Aukrust P, Mjoen G (2021)
The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
BMC Infect. Dis., 21 (1), 137
DOI 10.1186/s12879-021-05789-2

Fraz MSA, Moe N, Revheim ME, Stavrinou ML, Durheim MT, Nordoy I, Macpherson ME, Aukrust P, Jorgensen SF, Aalokken TM, Fevang B (2021)
Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and F-18-FDG Positron Emission Tomography/CT in Clinically Progressive Disease
Front. Immunol., 11, 617985
DOI 10.3389/fimmu.2020.617985

Hustad NB, Degerud HM, Hjelmerud I, Fraz MSA, Nordoy I, Troseid M, Fevang B, Aukrust P, Jorgensen SF (2021)
Real-World Experiences With Facilitated Subcutaneous Immunoglobulin Substitution in Patients With Hypogammaglobulinemia, Using a Three-Step Ramp-Up Schedule
Front. Immunol., 12, 670547
DOI 10.3389/fimmu.2021.670547

Jorgensen SF, Buechner J, Myhre AE, Galteland E, Spetalen S, Kulseth MA, Sorte HS, Holla OL, Lundman E, Alme C, Heier I, Flaegstad T, Floisand Y, Benneche A, Fevang B, Aukrust P, Stray-Pedersen A, Gedde-Dahl T, Nordoy I (2021)
A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT
J. Clin. Immunol.
DOI 10.1007/s10875-021-01189-y

Ueland T, Heggelund L, Lind A, Holten AR, Tonby K, Michelsen AE, Jenum S, Jorgensen MJ, Barratt-Due A, Skeie LG, Nordoy I, Fraz MSA, Quist-Paulsen E, Pischke SE, Johal SK, Hesstvedt L, Bogen M, Fevang B, Halvorsen B, Muller F, Bekken GK, Mollnes TE, Dudman S, Aukrust P, Dyrhol-Riise AM et al. (2021)
Elevated plasma sTIM-3 levels in patients with severe COVID-19
J. Allergy Clin. Immunol., 147 (1), 92-98
DOI 10.1016/j.jaci.2020.09.007

Publications 2020

Helset E, Nordoy I, Sporsem H, Bakke VD, Bugge JF, Gammelsrud KW, Zucknick M, von der Lippe E (2020)
Factors increasing the risk of inappropriate vancomycin therapy in ICU patients: A prospective observational study
Acta Anaesthesiol. Scand., 64 (9), 1295-1304
DOI 10.1111/aas.13658

Publications 2019

Hesstvedt L, Gaustad P, Muller F, Andersen CT, Brunborg C, Mylvaganam H, Leiva RA, Berdal JE, Ranheim TE, Johnsen BO, Falch BM, Grimnes G, Skogen V, Haarr E, Lyngoy AS, Larssen KW, Hannula R, Hansen BA, Nordoy I, Torfoss D, Gammelsrud KW, Kanestrom A, Ringstad J, Grub C, Sandnes RA et al. (2019)
The impact of age on risk assessment, therapeutic practice and outcome in candidemia
Infect. Dis., 51 (6), 425-434
DOI 10.1080/23744235.2019.1595709

Publications 2018

Nordoy I, Hesstvedt L, Andersen CT, Mylvaganam H, Kols NI, Falch BM, Tofteland S, Muller F, Denning DW (2018)
An Estimate of the Burden of Fungal Disease in Norway
J. Fungi, 4 (1), 29
DOI 10.3390/jof4010029

Nordoy I, Lutro O, Longva JA, Bekken GK, Simonsen HE (2018)
Outdated guidelines on antibiotic use
Tidsskr. Nor. Laegeforen., 138 (18), 1691-1692

Troseid M, Nordoy I, Fevang B, Aukrust P (2018)
Tenders for HIV medicines are not academically justified
Tidsskr. Nor. Laegeforen., 138 (20), 1912-1913

Publications 2017

Bakke V, Sporsem H, Von der Lippe E, Nordoy I, Lao Y, Nyrerod HC, Sandvik L, Harvig KR, Bugge JF, Helset E (2017)
Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study
Acta Anaesthesiol. Scand., 61 (6), 627-635
DOI 10.1111/aas.12897

Hesstvedt L, Arendrup MC, Poikonen E, Klingpor L, Friman V, Nordoy I, Swedish Fungal Surveillance Grp Co (2017)
Differences in epidemiology of candidaemia in the Nordic countries - what is to blame?
Mycoses, 60 (1), 11-19
DOI 10.1111/myc.12535

Jorgensen SF, Macpherson ME, Bjoro K, Karlsen TH, Reims HM, Grzyb K, Fosby B, Fevang B, Aukrust P, Nordoy I (2017)
Liver transplantation in patients with primary antibody deficiency
J. Allergy Clin. Immunol., 139 (5), 1708-+
DOI 10.1016/j.jaci.2016.10.025

Schlums H, Jung M, Han HY, Theorell J, Bigley V, Chiang SCC, Allan DSJ, Davidson-Moncada JK, Dickinson RE, Holmes TD, Hsu AP, Townsley D, Winkler T, Wang WX, Aukrust P, Nordoy I, Calvo KR, Holland SM, Collin M, Dunbar CE, Bryceson YT (2017)
Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells
Blood, 129 (14), 1927-1939
DOI 10.1182/blood-2016-08-734236

Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Akdemir ZHC, Erichsen HC, Forbes LR, Gu S, Yuan B, Jhangiani SN, Muzny DM, Rodningen OK, Sheng Y, Nicholas SK, Noroski LM, Seeborg FO, Davis CM, Canter DL, Mace EM, Vece TJ, Allen CE, Abhyankar HA, Boone PM, Beck CR et al. (2017)
Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders
J. Allergy Clin. Immunol., 139 (1), 232-245
DOI 10.1016/j.jaci.2016.05.042

Vikum D, Nordoy I, Andersen CT, Fevang B, Line PD, Kolrud FK, Aukrust P, Buanes T (2017)
A Young, Immunocompetent Woman with Small Bowel and Hepatic Mucormycosis Successfully Treated with Aggressive Surgical Debridements and Antifungal Therapy
Case Rep. Infect. Dis., 2017, 4173246
DOI 10.1155/2017/4173246

Publications 2015

Hesstvedt L, Gaustad P, Andersen CT, Haarr E, Hannula R, Haukland HH, Hermansen NO, Larssen KW, Mylvaganam H, Ranheim TE, Sandven P, Nordoy I, Kanestrom A, Grub C, Onken A, Thielsen C, Skaare D, Tofteland S, Sonsteby LJ, Hjetland R, Hide R, Vik E, Kummel A, Asheim S, Norwegian Yeast Study Grp (2015)
Twenty-two years of candidaemia surveillance: results from a Norwegian national study
Clin. Microbiol. Infect., 21 (10), 938-945
DOI 10.1016/j.cmi.2015.06.008

Hoyvoll LR, Floisand Y, Orrem HL, Gunnarsson R, Landro L, Brevig T, Gaustad P, Nordoy I (2015)
Hemophagocytic lymphohistiocytosis in leprosy
Lepr. Rev., 86 (4), 403-406

Publications 2014

Tortorano AM, Prigitano A, Esposto MC, Arsenijevic VA, Kolarovic J, Ivanovic D, Paripovic L, Klingspor L, Nordoy I, Hamal P, Akdagli SA, Ossi C, Grancini A, Cavanna C, Lo Cascio G, Scarparo C, Candoni A, Caira M, Apiranthitou MD, ECMM Working Grp (2014)
European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe
Eur. J. Clin. Microbiol. Infect. Dis., 33 (9), 1623-1630
DOI 10.1007/s10096-014-2111-1

Publications 2010

Johnsen BO, Lingaas E, Torfoss D, Strom EH, Nordoy I (2010)
A large outbreak of Listeria monocytogenes infection with short incubation period in a tertiary care hospital
J. Infect., 61 (6), 465-470
DOI 10.1016/j.jinf.2010.08.007

Publications 2004

Bjerkeli V, Halvorsen B, Damas JK, Nordoy I, Yndestad A, Aukrust P, Froland SS (2004)
Expression of matrix metalloproteinases in patients with Wegener's granulomatosis
Ann. Rheum. Dis., 63 (12), 1659-1663
DOI 10.1136/ard.2003.017954

Publications 2003

Holm T, Damas JK, Holven K, Nordoy I, Brosstas FR, Ueland T, Wahre T, Kjekshus J, Froland SS, Eiken HG, Solum NO, Gullestad L, Nenseter M, Aukrust P (2003)
CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells
J. Thromb. Haemost., 1 (2), 257-262
DOI 10.1046/j.1538-7836.2003.00065.x

Nordoy I, Rollag H, Lien E, Sindre H, Degre M, Aukrust P, Froland SS, Muller F (2003)
Cytomegalovirus infection induces production of human interleukin-10 in macrophages
Eur. J. Clin. Microbiol. Infect. Dis., 22 (12), 737-741
DOI 10.1007/s10096-003-1028-x

Publications 2002

Muller F, Tjonnfjord GE, Nordoy I, Kvale D, Mellbye OJ, Aukrust R, Froland SS (2002)
Immunophenotypic analyses of CD34(+) cell subsets in bone marrow from HIV-infected patients during highl-yactive antiretroviral therapy
Eur. J. Clin. Invest., 32 (7), 535-540
DOI 10.1046/j.1365-2362.2002.00995.x

Publications 2001

Stylianou E, Aukrust P, Muller F, Nordoy I, Froland SS (2001)
Complex effects of interferon-alpha on the cytokine network in HIV infection - Possible contribution to immunosuppression
Cytokine, 14 (1), 56-62
DOI 10.1006/cyto.2000.0850

Publications 2000

Muller F, Svardal AM, Nordoy I, Berge RK, Aukrust P, Froland SS (2000)
Virological and immunological effects of antioxidant treatment in patients with HIV infection
Eur. J. Clin. Invest., 30 (10), 905-914
DOI 10.1046/j.1365-2362.2000.00727.x

Nordoy I, Muller F, Nordal KP, Rollag H, Aukrust P, Froland SS (2000)
Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection
Clin. Exp. Immunol., 120 (2), 333-337
DOI 10.1046/j.1365-2249.2000.01221.x

Nordoy I, Muller F, Nordal KP, Rollag H, Lien E, Aukrust P, Froland SS (2000)
The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients
J. Infect. Dis., 181 (1), 51-57
DOI 10.1086/315184

Nordøy I (2000)
Cytomegalovirus infection in the adult immunocompromised patient: possible protective and pathogenic roles of the immune response
Section of Clinical Immunology and Infectious Diseases, Research Institute of Internal Medicine, Medical Department, Rikshospitalet, University of Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 000803065, ISBN 82-7722-133-9

Stylianou E, Aukrust P, Nordoy I, Muller F, Froland SS (2000)
Enhancement of lymphocyte proliferation induced by interleukin-12 and anti-interleukin-10 in HIV-infected patients during highly active antiretroviral therapy
APMIS, 108 (9), 601-607
DOI 10.1034/j.1600-0463.2000.d01-1410.x

Publications 1999

Aukrust P, Muller F, Lien E, Nordoy I, Liabakk NB, Kvale D, Espevik T, Froland SS (1999)
Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: Persistent TNF activation is associated with virologic and immunologic treatment failure
J. Infect. Dis., 179 (1), 74-82
DOI 10.1086/314572

Aukrust P, Muller F, Svenson M, Nordoy I, Bendtzen K, Froland SS (1999)
Administration of intravenous immunoglobulin (IVIG) in vivo-down-regulatory effects on the IL-1 system
Clin. Exp. Immunol., 115 (1), 136-143

Aukrust P, Ueland T, Lien E, Bendtzen K, Muller F, Andreassen AK, Nordoy I, Aass H, Espevik T, Simonsen S, Froland SS, Gullestad L (1999)
Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
Am. J. Cardiol., 83 (3), 376-382
DOI 10.1016/S0002-9149(98)00872-8

Aukrust P, Aandahl EM, Skalhegg BS, Nordoy I, Hansson V, Tasken K, Froland SS, Muller F (1999)
Increased activation of protein kinase a type I contributes to the T cell deficiency in common variable immunodeficiency
J. Immunol., 162 (2), 1178-1185

Nordoy I, Muller F, Nordal KP, Rollag H, Lien E, Aukrust P, Froland SS (1999)
Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients
J. Infect. Dis., 180 (1), 195-198
DOI 10.1086/314849

Nordøy I, Lien E (1999)
Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients
Infectious Diseases Society of America, [Chicago], S. 195-198.
BIBSYS 00022796x

Publications 1998

Andreassen AK, Nordoy I, Simonsen S, Ueland T, Muller F, Froland SS, Gullestad L, Aukrust P (1998)
Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation
Am. J. Cardiol., 81 (5), 604-608
DOI 10.1016/S0002-9149(97)00972-7

Aukrust P, Ueland T, Muller F, Andreassen AK, Nordoy I, Aas H, Kjekshus J, Simonsen S, Froland SS, Gullestad L (1998)
Elevated circulating levels of C-C chemokines in patients with congestive heart failure
Circulation, 97 (12), 1136-1143
DOI 10.1161/01.CIR.97.12.1136

Muller F, Aukrust P, Nordoy I, Froland SS (1998)
Possible role of interleukin-10 (IL-10) and CD40 ligand expression in the pathogenesis of hypergammaglobulinemia in human immunodeficiency virus infection: Modulation of IL-10 and Ig production after intravenous Ig infusion
Blood, 92 (10), 3721-3729
DOI 10.1182/blood.V92.10.3721.422k11_3721_3729

Nordoy I, Muller F, Aukrust P, Froland SS (1998)
Adhesion molecules in common variable immunodeficiency (CVID) - a decrease in L-selectin-positive T lymphocytes
Clin. Exp. Immunol., 114 (2), 258-263

Publications 1997

Aukrust P, Hestdal K, Lien E, Bjerkeli V, Nordoy I, Espevik T, Muller F, Froland SS (1997)
Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection
J. Infect. Dis., 176 (4), 913-923
DOI 10.1086/516510

Aukrust P, Muller F, Nordoy I, Haug CJ, Froland SS (1997)
Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo
Clin. Exp. Immunol., 107 (1), 50-56
DOI 10.1046/j.1365-2249.1997.d01-904.x

Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, VonderLippe B, Raknerud N, Skaug K, Gutigard BG, Skjaerven R, Prescott LE, Simmonds P, Bucher A, Lind E, Schulz T, Sundoy A, Barstad S, Storseth P, Nordoy I, Bjark P, Anfinsen OG, Klem K, Stray N, Weberg R et al. (1997)
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C
Scand. J. Infect. Dis., 29 (1), 17-22
DOI 10.3109/00365549709008658

Nordoy I, Krarup HB, Bell H, Christensen PB, Elgjo K, Von der Lippe B, De Muckadell OS, Maeland A, Ring-Larsen H, Samdal HH, Simmonds P, Skaug K, Tage-Jensen U, Schrumpf E (1997)
Interferon-alpha 2b therapy in low-activity hepatitis C: A pilot study
Scand. J. Gastroenterol., 32 (12), 1256-1260
DOI 10.3109/00365529709028156

Publications 1996

Aukrust P, Svardal AM, Muller F, Lunden B, Nordoy I, Froland SS (1996)
Markedly disturbed glutathione redox status in CD45RA(+)CD4(+) lymphocytes in human immunodeficiency virus type 1 infection is associated with selective depletion of this lymphocyte subset
Blood, 88 (7), 2626-2633
DOI 10.1182/blood.V88.7.2626.bloodjournal8872626

Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, VonderLippe B, Raknerud N, Skaug K, Prescott L, Simmonds P, Bucher A, Lind E, Schulz T, Sundoy A, Barstad S, Storset S, Nordoy I, Bjark P, Anfinsen OG, Klem K, Stray N, Weberg R, Melsom M, Mosvold J et al. (1996)
Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway
Scand. J. Infect. Dis., 28 (4), 357-359
DOI 10.3109/00365549609037919

Nordoy I, Aukrust P, Muller F, Froland SS (1996)
Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections
Clin. Immunol. Immunopathol., 81 (1), 16-21
DOI 10.1006/clin.1996.0151

Publications 1994

AUKRUST P, FROLAND SS, LIABAKK NB, MULLER F, NORDOY I, HAUG C, ESPEVIK T (1994)
RELEASE OF CYTOKINES, SOLUBLE CYTOKINE RECEPTORS, AND INTERLEUKIN-1 RECEPTOR ANTAGONIST AFTER INTRAVENOUS IMMUNOGLOBULIN ADMINISTRATION IN-VIVO
Blood, 84 (7), 2136-2143

NORDOY I, SCHRUMPF E, ELGJO K, FLESLAND O, GLENDE JA, ORJASAETER H, SIEBKE JC (1994)
LIVER-DISEASE IN ANTI-HEPATITIS-C VIRUS-POSITIVE NORWEGIAN BLOOD-DONORS
Scand. J. Gastroenterol., 29 (1), 77-81
DOI 10.3109/00365529409090441